title: Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system?
authors.forename: Satomi
authors.initials: S
authors.lastname: Onoue
authors.forename: Satomi
authors.initials: S
authors.lastname: Yamada
mesh_terms: D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D017484:Dermatitis, Phototoxic / Q000209:etiology; D006801:Humans; D011208:Powders; D011658:Pulmonary Fibrosis / Q000188:drug therapy*; D011728:Pyridones / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011208:Powders; D011728:Pyridones; C093844:pirfenidone